Home › Glioblastoma › Pennsylvania › Philadelphia

Pag-aaral pangklinika para sa Glioblastoma sa Philadelphia, PA

Isang pag-aaral para sa Glioblastoma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Philadelphia. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

Nagre-recruitPhase 2

Thomas Jefferson University, Sidney Kimmel Comprehensive Cancer Center, Philadelphia

Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07326566

A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

Nagre-recruitPhase 1/2

Children's Hospital of Philadelphia-Center for Childhood Cancer Research, Philadelphia

Hanggang edad 25 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT04094610

Multitracer [18F]Fluciclovine and 18F-FDG PET, and Advanced MRI for Metabolic Profiling of Glioblastoma

Nagre-recruitMaagang Phase 1

Hospital of the University of Pennsylvania, Philadelphia
University of Pennsylvania, Philadelphia

Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2026 · NCT06613841

Targeted Pediatric High-Grade Glioma Therapy

Nagre-recruitObservasyonal na pag-aaral

Children's Hospital of Philadelphia, Philadelphia

12 Months – 39 Years · Lahat ng kasarian · Na-update Set 8, 2026 · NCT05839379

Study of Olutasidenib and Temozolomide in HGG

Nagre-recruitPhase 2

Children's Hospital of Philadelphia, Philadelphia

Edad 12 hanggang 39 · Lahat ng kasarian · Na-update Set 1, 2026 · NCT06161974

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

Nagre-recruitPhase 3

Thomas Jefferson University Hospital, Philadelphia

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT05303519

WBSI Guided Personalized Delivery of TTFields

Nagre-recruit

Abramson Cancer Center, Philadelphia
Penn Medicine, University of Pennsylvania, Philadelphia

Edad 22 pataas · Lahat ng kasarian · Na-update Ago 6, 2026 · NCT05086497

Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion

Nagre-recruitMaagang Phase 1Malugod na tinatanggap ang malusog na boluntaryo

Children's Hospital of Philadelphia, Philadelphia

Edad 1 hanggang 21 · Lahat ng kasarian · Na-update Hun 29, 2026 · NCT06333899

ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors

Nagre-recruitPhase 1

Children's Hospital of Philadelphia, Philadelphia

Edad 2 hanggang 21 · Lahat ng kasarian · Na-update Hun 11, 2026 · NCT04732065

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

Nagre-recruitPhase 2

Children's Hospital of Philadelphia, Philadelphia

12 Months – 39 Years · Lahat ng kasarian · Na-update May 29, 2026 · NCT05843253

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Nagre-recruitObservasyonal na pag-aaral

Massive Bio SYNERGY-AI site, Philadelphia

Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774

Pag-aaral para sa Glioblastoma sa ibang lungsod

Iba pang pag-aaral sa Philadelphia

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.